Thursday, January 14, 2021
Johnson & Johnson COVID-19 vaccine induces immune response after 1 dose: study
Pharmaceutical giant Johnson & Johnson on Wednesday published early data for its coronavirus vaccine, showing a lasting immune response and tolerability among trial volunteers. According to the findings, published in the New England Journal of Medicine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment